Innovation Parenteral Private Limited
About Innovation Parenteral Private Limited
Data last updated:
Innovation Parenteral Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2014PTC045827. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chitraj Avasthi and Vinay Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Plot No. 66 Shopping Centre Shastri Nagar, Jaipur, Rajasthan, India – 302016.
As per the financials filed for FY 2018, the company reported a revenue of ₹89.07 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹15,809 (net margin -0.2%) and EBITDA of -₹15,667 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Innovation Parenteral Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 66 Shopping Centre Shastri Nagar, Jaipur, Rajasthan, India – 302016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Innovation Parenteral Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Innovation Parenteral is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Innovation Parenteral Private Limited, buy the company report.
Financials of Innovation Parenteral Private Limited
FY 2019 filings availableInnovation Parenteral Private Limited reported revenue of ₹89.07 Lakh (down 19% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 18%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹89.07 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹15,667 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹15,809 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.2% | |||
| Net Profit Margin | -0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Innovation Parenteral Private Limited, buy the company report.
Board of directors of Innovation Parenteral Private Limited
Innovation Parenteral has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chitraj Avasthi | Director | 27 Jun 2014 | 12 Years 4 Months | Current |
| Vinay Choudhary | Additional Director | 20 Jan 2017 | 9 Years 9 Months | Current |
Auditor
Innovation Parenteral Private Limited is audited by AJMERA BANSAL & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJMERA BANSAL & ASSOCIATES | FY 2018 | 015645C |
Shareholding
The shareholding of Innovation Parenteral Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Innovation Parenteral Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Innovation Parenteral Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innovation Parenteral Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innovation Parenteral has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Innovation Parenteral Private Limited, buy the company report.
Recent activity
Innovation Parenteral Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Rajiv Mittal ceased to be Director on 23 Jan 2017.
Frequently asked questions
Innovation Parenteral is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 June 2014 (12+ years old) and is registered under CIN U24232RJ2014PTC045827.
Innovation Parenteral has 2 current directors:
- Chitraj Avasthi - Director
- Vinay Choudhary - Additional Director
The latest financial statements of Innovation Parenteral on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Innovation Parenteral has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Innovation Parenteral is U24232RJ2014PTC045827. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innovation Parenteral was incorporated on 27 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Jaipur.
Rajiv Mittal ceased to be Director on 23 Jan 2017. Vinay Choudhary was appointed as Additional Director on 20 Jan 2017. Chitraj Avasthi was appointed as Director on 27 Jun 2014. Innovation Parenteral has 4 board changes on record in total.
The registered office of Innovation Parenteral is at Plot No. 66 Shopping Centre Shastri Nagar, Jaipur, Rajasthan, India – 302016.
Innovation Parenteral operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Innovation Parenteral is compliant as of 30 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
